Min-Wu Chao

May 9, 2024 | onlinelibrary.wiley.com | Cheng-Chiao Huang |Chia-Ming K. Hsu |Min-Wu Chao |Kai-Cheng Hsu

1 INTRODUCTION Breast cancer (BC) is the most common cancer among women globally, and its incidence continues to rise annually. BC can be categorized based on the expression status of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth receptor 2 (HER2). Remarkable progress has been made in developing targeted therapies for these biomarkers, significantly improving both patient survival rates and progression-free survival.